GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 802.7 INR -3.89% Market Closed
Market Cap: 474.8B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd

Wall Street analysts forecast GLAXO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAXO is 2 670.11 INR with a low forecast of 2 191.7 INR and a high forecast of 3 412.5 INR.

GLAXO Lowest Forecast
Wall Street Target
2 191.7 INR
22% Downside
GLAXO Average Forecast
Wall Street Target
2 670.11 INR
5% Downside
GLAXO Highest Forecast
Wall Street Target
3 412.5 INR
22% Upside
Lowest
Price Target
2 191.7 INR
22% Downside
Average
Price Target
2 670.11 INR
5% Downside
Highest
Price Target
3 412.5 INR
22% Upside
GlaxoSmithKline Pharmaceuticals Ltd Competitors:
Price Targets
G
GLENMARK
Glenmark Pharmaceuticals Ltd
26% Upside
I
IMP
Imexpharm Corp
8% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
51% Upside
ITRM
Iterum Therapeutics PLC
305% Upside
G
GLENMARK
Glenmark Pharmaceuticals Ltd
26% Upside
I
IMP
Imexpharm Corp
8% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
51% Upside
ITRM
Iterum Therapeutics PLC
305% Upside
SUPRIYA
Supriya Lifescience Ltd
8% Downside

Revenue
Forecast

Revenue Estimate
GlaxoSmithKline Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for GlaxoSmithKline Pharmaceuticals Ltd's revenue is 2%. The projected CAGR for the next 3 years is 11%.

2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
GlaxoSmithKline Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for GlaxoSmithKline Pharmaceuticals Ltd's operating income is 8%. The projected CAGR for the next 3 years is 18%.

8%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
GlaxoSmithKline Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for GlaxoSmithKline Pharmaceuticals Ltd's net income is 6%. The projected CAGR for the next 3 years is 26%.

6%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
GLAXO intrinsic value, competitors valuation, and company profile.
DCF Valuation
GLAXO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GLAXO stock valuation using valuation multiples.
Wall Street Estimates
GLAXO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GLAXO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLAXO's stock price target?
Price Target
2 670.11 INR

According to Wall Street analysts, the average 1-year price target for GLAXO is 2 670.11 INR with a low forecast of 2 191.7 INR and a high forecast of 3 412.5 INR.

What is GlaxoSmithKline Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for GlaxoSmithKline Pharmaceuticals Ltd's revenue is 2%. The projected CAGR for the next 3 years is 11%.

What is GlaxoSmithKline Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for GlaxoSmithKline Pharmaceuticals Ltd's operating income is 8%. The projected CAGR for the next 3 years is 18%.

What is GlaxoSmithKline Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for GlaxoSmithKline Pharmaceuticals Ltd's net income is 6%. The projected CAGR for the next 3 years is 26%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.